Knowing how often each cause occurs sets the probability behind pattern recognition: the same symptom points to different diseases in a 70-year-old with diabetes and in a 30-year-old without it. The figures below are what that probability rests on. Two terms recur: incidence counts new cases over a period, and prevalence counts everyone affected at a given time.
How common polyneuropathy is
Population studies that examine people directly put clinically defined polyneuropathy at roughly 1 to 3% of adults, rising to about 7% in older adults. The estimates scatter widely because the definition changes the result. In a general population cohort examined in detail, chronic axonal polyneuropathy had an age-standardized prevalence of about 3% for the United States and Europe, and more than half of the affected participants had never been diagnosed. Surveys that count abnormal monofilament testing (a fine nylon filament pressed against the skin to test touch) instead of a full clinical and electrodiagnostic assessment report much higher figures, above 13% of adults aged 40 and over, which reflects mild sensory loss rather than diagnosed disease.
Diabetes and prediabetes
Diabetes is the single most common identified cause of polyneuropathy. Pooled estimates put diabetic peripheral neuropathy at about 30% of people with diabetes, higher in type 2 than in type 1 (about 31% versus 18%), and roughly half of those affected have no symptoms. Prevalence rises with age, duration of diabetes, and poor glycemic control, so the clinical setting matters more than any single figure.
Prediabetes contributes too, though its size is disputed. Prevalence estimates for neuropathy in people with impaired glucose tolerance range from about 2% to over 70% depending on the tests used, with most studies reporting at least 10%.
Immune-mediated and inherited neuropathies
These are rarer than metabolic and toxic disease, but each is worth recognizing because treatment or genetic counseling follows. The table sets the frequencies side by side.
| Condition | Frequency | Points to remember |
|---|---|---|
| Guillain-Barre syndrome | about 1 to 2 new cases per 100,000 people per year | more common in males, and incidence rises with age |
| CIDP (chronic inflammatory demyelinating polyradiculoneuropathy) | about 0.3 new cases per 100,000 per year, prevalence about 3 per 100,000 | chronic, so prevalence exceeds incidence |
| Multifocal motor neuropathy | about 0.6 per 100,000 | rare but treatable mimic of motor neuron disease |
| Charcot-Marie-Tooth disease | commonly cited as about 1 in 2,500, with pooled estimates lower than that | the most common inherited neuropathy |
| Hereditary neuropathy with liability to pressure palsies | about 7 to 16 per 100,000 | usually a PMP22 deletion, also called HNPP |
Compression neuropathies
Carpal tunnel syndrome is the most common focal neuropathy, with an estimated prevalence of about 3 to 5% in the general adult population and women affected about twice as often as men. Population surveys in the United States found that 8% of adults reported ever receiving the diagnosis, and 3.6% reported it in the previous year. Cubital tunnel syndrome is considerably less common. Because compression is so frequent, it is often found alongside a polyneuropathy rather than instead of one.
What the numbers change in practice
Two consequences follow. First, the common causes deserve testing first: in distal symmetric polyneuropathy, history and examination identify a cause in roughly 60% of patients and screening laboratory tests add about 10%, leaving about 30% idiopathic. Second, across all neuropathies, roughly a quarter to a half remain unexplained after routine workup, and idiopathic cases cluster at older ages where several mild contributors coexist. Rarer causes are worth pursuing when the pattern is atypical, the course is aggressive, or the family history points elsewhere.